In patients resistant to 1st/2nd generation EGFR-TKIs, SCLC transformation occurred in 1 out of 92 patients without ARAF amplification and 1 out of 5 patients with ARAF amplification (p = 0.10). Here, EGFR is linked to small cell lung carcinoma.